nach oben

European Journal of Trauma and Emergency Surgery

Erschienen in:

09.06.2023 | Original Article

Gut barrier protein levels in serial blood samples from critically ill trauma patients during and after intensive care unit stay

verfasst von: Hamiyet Donmez-Altuntas, Serap Sahin Ergul, Pinar Altin-Celik, Kadir Bulut, Hamiyet Eci̇roglu, Ramazan Uzen, Gulsah Gunes Sahin, Nurhayat Tugra Ozer, Sahin Temel, Turkmen Bahadir Arikan, Aliye Esmaoglu, Recep Civan Yuksel, Murat Sungur, Kursat Gundogan

Erschienen in: European Journal of Trauma and Emergency Surgery | Ausgabe 5/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

In an effort to better manage critically ill patients hospitalised in the intensive care unit (ICU) after experiencing multiple traumas, the present study aimed to assess whether plasma levels of intestinal epithelial cell barrier proteins, including occludin, claudin-1, junctional adhesion molecule (JAM-1), tricellulin and zonulin, could be used as novel biomarkers. Additional potential markers such as intestinal fatty acid-binding protein (I-FABP), d-lactate, lipopolysaccharide (LPS) and citrulline were also evaluated. We also aimed to determine the possible relationships between the clinical, laboratory, and nutritional status of patients and the measured marker levels.

Methods

Plasma samples from 29 patients (first, second, fifth and tenth days in the ICU and on days 7, 30 and 60 after hospital discharge) and 23 controls were subjected to commercial enzyme-linked immunosorbent assay (ELISA) testing.

Results

On first day (admission) and on the second day, plasma I-FABP, d-lactate, citrulline, occludin, claudin-1, tricellulin and zonulin levels were high in trauma patients and positively correlated with lactate, C-reactive protein (CRP), number of days of ICU hospitalisation, Acute Physiology and Chronic Health Evaluation II (APACHE II) score and daily Sequential Organ Failure Assessment (SOFA) scores (P < 0.05–P < 0.01).

Conclusion

The results of the present study showed that occludin, claudin-1, tricellulin and zonulin proteins, as well as I-FABP, d-lactate and citrulline, may be used as promising biomarkers for the evaluation of disease severity in critically ill trauma patients, despite the complexity of the analysis of various barrier markers. However, our results should be supported by future studies.

Nur mit Berechtigung zugänglich

Puleo F, Arvanitakis M, Van Gossum A, Preiser J-C. Gut failure in the ICU. Semin Respir Crit Care Med. 2011;32(5):626–38.PubMedCrossRef

Ackland G, Grocott MP, Mythen MG. Understanding gastrointestinal perfusion in critical care: so near, and yet so far. Crit Care. 2000;4(5):1–13.CrossRef

Denk S, Wiegner R, Hönes FM, Messerer DA, Radermacher P, Weiss M, Kalbitz M, Ehrnthaller C, Braumüller S, McCook O. Early detection of junctional adhesion molecule-1 (JAM-1) in the circulation after experimental and clinical polytrauma. Mediators Inflamm. 2015;2015:1–7.CrossRef

Reintam Blaser A, Jakob SM, Starkopf J. Gastrointestinal failure in the ICU. Curr Opin Crit Care. 2016;22(2):128–41.PubMed

Li H, Chen Y, Huo F, Wang Y, Zhang D. Association between acute gastrointestinal injury and biomarkers of intestinal barrier function in critically ill patients. BMC Gastroenterol. 2017;17:1–8.CrossRef

Asrani VM, Brown A, Huang W, Bissett I, Windsor JA. Gastrointestinal dysfunction in critical illness: a review of scoring tools. J Parenter Enter Nutr. 2020;44(2):182–96.CrossRef

Reintam Blaser A, Preiser J-C, Fruhwald S, Wilmer A, Wernerman J, Benstoem C, Casaer MP, Starkopf J, van Zanten A, Rooyackers O. Gastrointestinal dysfunction in the critically ill: a systematic scoping review and research agenda proposed by the Section of Metabolism, Endocrinology and Nutrition of the European Society of Intensive Care Medicine. Crit Care. 2020;24:1–17.CrossRef

Zhang X, Wang L, Chen D-C. Effect of rhubarb on gastrointestinal dysfunction in critically III patients: a retrospective study based on propensity score matching. Chin Med J. 2018;131(10):1142–50.PubMedPubMedCentralCrossRef

Blaser A, Padar M, Tang J, Dutton J, Forbes A. Citrulline and intestinal fatty acid-binding protein as biomarkers for gastrointestinal dysfunction in the critically ill. Anaesthesiol Intensive Ther. 2019;51(3):230–9.PubMedCrossRef

10.

Ewaschuk JB, Naylor JM, Zello GA. d-lactate in human and ruminant metabolism. J Nutr. 2005;135(7):1619–25.PubMedCrossRef

11.

Fragkos KC, Forbes A. Citrulline as a marker of intestinal function and absorption in clinical settings: a systematic review and meta-analysis. United Eur Gastroenterol J. 2018;6(2):181–91.CrossRef

12.

Ghosh SS, Wang J, Yannie PJ, Ghosh S. Intestinal barrier dysfunction, LPS translocation, and disease development. J Endocrine Soc. 2020;4(2):bvz039.CrossRef

13.

Monroe GR, van Eerde AM, Tessadori F, Duran KJ, Savelberg SM, van Alfen JC, Terhal PA, van der Crabben SN, Lichtenbelt KD, Fuchs SA. Identification of human D lactate dehydrogenase deficiency. Nat Commun. 2019;10(1):1477.PubMedPubMedCentralCrossRef

14.

Moonen P-J, Blaser A, Starkopf J, Oudemans-van Straaten H, Van der Mullen J, Vermeulen G, Malbrain M. The black box revelation: monitoring gastrointestinal function. Anestezjol Intens Ter. 2019;50(1):73–82.

15.

Peoc’h K, Nuzzo A, Guedj K, Paugam C, Corcos O. Diagnosis biomarkers in acute intestinal ischemic injury: so close, yet so far. Clin Chem Lab Med (CCLM). 2018;56(3):373–85.PubMedCrossRef

16.

Piton G, Manzon C, Cypriani B, Carbonnel F, Capellier G. Acute intestinal failure in critically ill patients: is plasma citrulline the right marker? Intensive Care Med. 2011;37:911–7.PubMedCrossRef

17.

Pohanka M. d-lactic acid as a metabolite: toxicology, diagnosis, and detection. BioMed Res Int. 2020;2020:1–9.CrossRef

18.

Shi H, Wu B, Wan J, Liu W, Su B. The role of serum intestinal fatty acid binding protein levels and d-lactate levels in the diagnosis of acute intestinal ischemia. Clin Res Hepatol Gastroenterol. 2015;39(3):373–8.PubMedCrossRef

19.

Voth M, Duchene M, Auner B, Lustenberger T, Relja B, Marzi I. I-FABP is a novel marker for the detection of intestinal injury in severely injured trauma patients. World J Surg. 2017;41:3120–7.PubMedCrossRef

20.

Garcia-Hernandez V, Quiros M, Nusrat A. Intestinal epithelial claudins: expression and regulation in homeostasis and inflammation. Ann N Y Acad Sci. 2017;1397(1):66–79.PubMedPubMedCentralCrossRef

21.

Groschwitz KR, Hogan SP. Intestinal barrier function: molecular regulation and disease pathogenesis. J Allergy Clin Immunol. 2009;124(1):3–20.PubMedPubMedCentralCrossRef

22.

Krug SM, Fromm M. Special issue on “The tight junction and its proteins: more than just a barrier.” Int J Mol Sci. 2020;21:4612.PubMedPubMedCentralCrossRef

23.

Lee B, Moon KM, Kim CY. Tight junction in the intestinal epithelium: its association with diseases and regulation by phytochemicals. J Immunol Res. 2018;2018:1–11.CrossRef

24.

Wang W, Uzzau S, Goldblum SE, Fasano A. Human zonulin, a potential modulator of intestinal tight junctions. J Cell Sci. 2000;113(24):4435–40.PubMedCrossRef

25.

Zeisel MB, Dhawan P, Baumert TF. Tight junction proteins in gastrointestinal and liver disease. Gut. 2019;68(3):547–61.PubMedCrossRef

26.

Halbgebauer R, Braun CK, Denk S, Mayer B, Cinelli P, Radermacher P, Wanner GA, Simmen H-P, Gebhard F, Rittirsch D. Hemorrhagic shock drives glycocalyx, barrier and organ dysfunction early after polytrauma. J Crit Care. 2018;44:229–37.PubMedCrossRef

27.

McClave SA, Taylor BE, Martindale RG, Warren MM, Johnson DR, Braunschweig C, McCarthy MS, Davanos E, Rice TW, Cresci GA. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (ASPEN). JPEN J Parenter Enteral Nutr. 2016;40(2):159–211.PubMedCrossRef

28.

Singer P, Blaser AR, Berger MM, Alhazzani W, Calder PC, Casaer MP, Hiesmayr M, Mayer K, Montejo JC, Pichard C. ESPEN guideline on clinical nutrition in the intensive care unit. Clin Nutr. 2019;38(1):48–79.PubMedCrossRef

29.

van Zanten ARH, De Waele E, Wischmeyer PE. Nutrition therapy and critical illness: practical guidance for the ICU, post-ICU, and long-term convalescence phases. Crit Care. 2019;23(1):1–10.

30.

Osuka A, Kusuki H, Matsuura H, Shimizu K, Ogura H, Ueyama M. Acute intestinal damage following severe burn correlates with the development of multiple organ dysfunction syndrome: a prospective cohort study. Burns J Int Soc Burn Injuries. 2017;43(4):824–9.CrossRef

31.

Blikslager AT, Moeser AJ, Gookin JL, Jones SL, Odle J. Restoration of barrier function in injured intestinal mucosa. Physiol Rev. 2007;87(2):545–64.PubMedCrossRef

32.

Slifer ZM, Blikslager AT. The integral role of tight junction proteins in the repair of injured intestinal epithelium. Int J Mol Sci. 2020;21(3):972.PubMedPubMedCentralCrossRef

33.

Kuo WT, Shen L, Zuo L, Shashikanth N, Ong M, Wu L, Zha J, Edelblum KL, Wang Y, Wang Y, Nilsen SP, Turner JR. Inflammation-induced occludin downregulation limits epithelial apoptosis by suppressing caspase-3 expression. Gastroenterology. 2019;157(5):1323–37.PubMedCrossRef

34.

Poritz LS, Harris LR, Kelly AA, Koltun WA. Increase in the tight junction protein claudin-1 in intestinal inflammation. Dig Dis Sci. 2011;56:2802–9.PubMedPubMedCentralCrossRef

35.

Zhu L, Han J, Li L, Wang Y, Li Y, Zhang S. Claudin family participates in the pathogenesis of inflammatory bowel diseases and colitis-associated colorectal cancer. Front Immunol. 2019;10:1441.PubMedPubMedCentralCrossRef

36.

Lameris AL, Huybers S, Kaukinen K, Mäkelä TH, Bindels RJ, Hoenderop JG, Nevalainen PI. Expression profiling of claudins in the human gastrointestinal tract in health and during inflammatory bowel disease. Scand J Gastroenterol. 2013;48(1):58–69.PubMedCrossRef

37.

Mineta K, Yamamoto Y, Yamazaki Y, Tanaka H, Tada Y, Saito K, Tamura A, Igarashi M, Endo T, Takeuchi K. Predicted expansion of the claudin multigene family. FEBS Lett. 2011;585(4):606–12.PubMedCrossRef

38.

Weber CR, Nalle SC, Tretiakova M, Rubin DT, Turner JR. Claudin-1 and claudin-2 expression is elevated in inflammatory bowel disease and may contribute to early neoplastic transformation. Lab Invest. 2008;88(10):1110–20.PubMedPubMedCentralCrossRef

39.

Cording J, Günther R, Vigolo E, Tscheik C, Winkler L, Schlattner I, Lorenz D, Haseloff RF, Schmidt-Ott KM, Wolburg H. Redox regulation of cell contacts by tricellulin and occludin: redox-sensitive cysteine sites in tricellulin regulate both tri-and bicellular junctions in tissue barriers as shown in hypoxia and ischemia. Antioxid Redox Signal. 2015;23(13):1035–49.PubMedCrossRef

40.

Ikenouchi J, Furuse M, Furuse K, Sasaki H, Tsukita S, Tsukita S. Tricellulin constitutes a novel barrier at tricellular contacts of epithelial cells. J Cell Biol. 2005;171(6):939–45.PubMedPubMedCentralCrossRef

41.

Krug S, Bojarski C, Fromm A, Lee I, Dames P, Richter J, Turner J, Fromm M, Schulzke J. Tricellulin is regulated via interleukin-13-receptor α2, affects macromolecule uptake, and is decreased in ulcerative colitis. Mucosal Immunol. 2018;11(2):345–56.PubMedCrossRef

42.

Fasano A. Leaky gut and autoimmune diseases. Clin Rev Allergy Immunol. 2012;42:71–8.PubMedCrossRef

43.

Fasano A, Not T, Wang W, Uzzau S, Berti I, Tommasini A, Goldblum SE. Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. Lancet. 2000;355(9214):1518–9.PubMedCrossRef

44.

Sturgeon C, Fasano A. Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases. Tissue Barriers. 2016;4(4): e1251384.PubMedPubMedCentralCrossRef

45.

Tripathi A, Lammers KM, Goldblum S, Shea-Donohue T, Netzel-Arnett S, Buzza MS, Antalis TM, Vogel SN, Zhao A, Yang S. Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2. Proc Natl Acad Sci. 2009;106(39):16799–804.PubMedPubMedCentralCrossRef

46.

Klaus DA, Motal MC, Burger-Klepp U, Marschalek C, Schmidt EM, Lebherz-Eichinger D, Krenn CG, Roth GA. Increased plasma zonulin in patients with sepsis. Biochem Med. 2013;23(1):107–11.CrossRef

47.

Moreno-Navarrete JM, Sabater M, Ortega F, Ricart W, Fernandez-Real JM. Circulating zonulin, a marker of intestinal permeability, is increased in association with obesity-associated insulin resistance. PLoS ONE. 2012;7(5): e37160.PubMedPubMedCentralCrossRef

48.

Żak-Gołąb A, Kocełak P, Aptekorz M, Zientara M, Juszczyk Ł, Martirosian G, Chudek J, Olszanecka-Glinianowicz M. Gut microbiota, microinflammation, metabolic profile, and zonulin concentration in obese and normal weight subjects. Int J Endocrinol. 2013;2013:1–9.CrossRef

49.

Robinson BD, Tharakan B, Lomas A, Wiggins-Dohlvik K, Alluri H, Shaji CA. Jupiter D, Isbell CL (2020) Exploring blood–brain barrier hyperpermeability and potential biomarkers in traumatic brain injury. In: Baylor University Medical Center proceedings: 2020. Taylor & Francis, pp 199–204

50.

Blaser AR, Padar M, Mändul M, Elke G, Engel C, Fischer K, Giabicani M, Gold T, Hess B, Hiesmayr M, Jakob SM, Loudet CI, Meesters DM, Mongkolpun W, Paugam-Burtz C, Poeze M, Preiser JC, Renberg M, Rooijackers O, Tamme K, Wernerman J, Starkopf J. Development of the gastrointestinal dysfunction score (GIDS) for critically ill patients—a prospective multicenter observational study (iSOFA study). Clin Nutr. 2021;40(8):4932–40.CrossRef

Titel: Gut barrier protein levels in serial blood samples from critically ill trauma patients during and after intensive care unit stay
verfasst von: Hamiyet Donmez-Altuntas
Serap Sahin Ergul
Pinar Altin-Celik
Kadir Bulut
Hamiyet Eci̇roglu
Ramazan Uzen
Gulsah Gunes Sahin
Nurhayat Tugra Ozer
Sahin Temel
Turkmen Bahadir Arikan
Aliye Esmaoglu
Recep Civan Yuksel
Murat Sungur
Kursat Gundogan
Publikationsdatum: 09.06.2023
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Trauma and Emergency Surgery / Ausgabe 5/2023
Print ISSN: 1863-9933
Elektronische ISSN: 1863-9941
DOI: https://doi.org/10.1007/s00068-023-02298-6

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Gut barrier protein levels in serial blood samples from critically ill trauma patients during and after intensive care unit stay